Impact of preoperative aortic cusp prolapse on long-term outcome after surgical closure of subarterial ventricular septal defect  by Cheung, Yiu-fai et al.
C~ 
O- 
406A ABSTRACTS - Pediatric Cardiology 
1120-98 Intreoperetive Transesophageal Echo for Repair of 
Aortic Insuffiency Does Not Predict Later Aortic Valve 
Function In Children 
Delohine Yuna, Karen Altmann, Walton M. Gersony, David E. Solowiejczyk, Jan M. 
Quaegebeur, Beth F. Printz, Columbia University College of Physicians and Surgeons, 
New York, New York. 
Background: There are reports that intra-operative transesophageat echo (intra-op 
TEE) is predictive of early and intermediate outcome following aortic valve (AoV) repair 
for aortic insufficiency (AI), However, the ability of intra-op TEE to predict later success of 
AoV repair in children is unknown. 
Methods: Seventeen pts (mean 8 yrs, range 3 mo-20 yrs) who underwent 18 AoV repair 
procedures with intre-op TEE from 9/95 - 9/00 were included. Nine pts had VSD with AoV 
prolapse, 4 congenitally abnormal AoV, 3 AI due to AoV injury at a prior op, and 1 
endocarditis. AoV function was assessed by intra-op TEE and compared with the most 
recent transthoracic echo (TTE). Degree of AI was graded qualitatively, 
Results: Data are shown below. Mean f/u time was 24 mo (3-63 mo). There were 9 
cases (8 pts) of post-op AI progression by more than one grade. Of these, 5 (4 pts) had 
VSD and AoV prolapse, Four pts required re-op for AI. Two had re-repair for acute pro- 
gressive AI due to suture dehiscence or tear; one of these pts required a 3rd AoV repair 
5 mo later. Two other pts required re-op 13 months (AoV replacement), and 27 months 
(Ross) following initial repair, Of these 5 cases (4 pts) who required re-op, 3 had none or 
tdvial AI, 1 mild AI, and 1 mild to moderate AI on post-op TEE. 
Conclusion: Post-op TEE assessment of aortic valve function following aortic valve 
repair was not predictive of AI or need for re-operation. There was no relation between 
the pre-op degree of AI, nor the mechanism of AI, and the progression of AI following 
aortic valve repair. 
AI Grade Pre-op TEE Post-op TEE Latest TTE 
Mild or less 6 16 5 
Mild-m0derate 1 1 4 
Moderate 2 1 4 
More than moderate 9 5 
1120-99 Hemodynamlc Effects of Sodium Nltroprusside After 
Superior Cevopulmonary Connection 
Janet M. Simsic. Scott M, Bradley, Denise M. Mulvihil4, Medical University of Soutb 
Carolina, Charleston, South Caro/ina. 
Background: Systemic hypertension is common in the earty postoperative period after 
superior cavopulmonary connection (SCC); it is typically treated with a vasodilator, 
sodium nitroprusside (SNP). SCC places the cerebral and pulmonary vascular beds in 
sedes. In this setting, the effects of SNP on cerebral blood flow, pulmonary blood flow 
and systemic oxygen saturation are unknown. Purpose: To determine the effects of SNP 
on cerebral blood flow velocity (CBFV), arferiovenous oxygen saturation difference, and 
systemic oxygen saturation after SCC. 
Methods: Nine patients (median age 7 mos; range 4 -12) undergoing SCC were pro- 
spectively studied in the ICU while sedated, paralyzed, and mechanically ventilated, 
CSFV was measured by transcranial Doppler of the middle cerebral artery. Each patient 
was studied at 3 time points: (1) baseline, (2) dudng SNP infusion, and (3) return to base- 
line. 
Results: SNP significantly lowered mean artedal blood pressure, but had no effects on 
CBFV, arteriovenous oxygen saturation difference, or systemic oxygenation. 
Conclusions: Following SCC, the vasodilator, SNP, has no deleterious effects on cere- 
bral blood flow or systemic oxygen saturation. SNP is thus an appropriate agent for treat- 
ment of postoperative systemic hypertension. This data also suggests that this aspect of 
cerebral autoregulafion is intact in the early postoperative period after SCC. 
(1) Baseline (2)SNP (3)Baseline 
Mean Arterial BP (mmHg) 69_+6 58_+6* 68_+6 
Transpulmonary gradient 6i2 6_+2 6_+2 
pH 7.40i0.03 7 .40 i - _0 .05  7.40i0.05 
pC02 (torr) 41-+4 41_+5 40-+5 
pO2 (torr) 49-+12 47+9 48+12 
Systemic 02 Sat (%) 84+7 81 -+6 81-+8 
SVC 02 Sat (%) 50-+14 47-+12 48-+12 
Systemic - SVC 02 Sat (%) 32+9 33-+9 33_+8 
CBFV (cm/sec) 54+_2 54_+1 58_+2 
Values are Mean+SD. CBFV = cerebral blood flow velocity. SVC = superior vena cava. 
*P<0.O5 vs. Baseline (ANOVA). 
1120-100 Impact  of  Preoperat ive Aor t i c  Cusp Prolapse on Long- 
Term Outcome After Surgical Closure of Subarter ia l  
Ventricular Septal Defect 
Yiu-fai Cheuno. Clement S. Chiu, Tak-cheung Yung, Adolphus K. Chau, The University of 
Hang Kong, I-long Kong, People's Republic of China. 
Background: Previous reports on the Iong-tarm outcome of surgical closure of subarterial 
ventricular septal defect (VSD) were based on a relatively small number of patients. 
Methods: We reviewed the long-term outcome of 135 patients who underwent closure of 
their defect and in light of the findings, to assess the impact of preoperative aortic cusp 
prolapse and surgical interventions on occurrence of aortic regurgitation (AR) in the tong- 
term. The patients were categorized into 3 groups for comparison: group I consisted of 
79 patients with no aortic cusp prolapse and underwent simple closure of VSD, group II 
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comprised 39 with mild to moderate cusp prolapse who similarly had only closure of the 
defect performed, while group III comprised 17 who had additional aortic valvoplasty for 
their moderate to severe cusp prolapse. 
Results: Group I patients had significantly higher pulmonary artedal pressure (p<0.001) 
and Qp:Qs ratio (p<0.001). None of these patients had AR prior to surgery and none 
developed AR afterwards at a median follow-up of 6.1 years. Of the 39 group II patients, 
30 (77%) had trivial or mild AR preoperatively. The AR improved in 15 patients, remained 
trivial or mild in 14 and absent in 7, but progressed to trivial or mild in 3 at a median fol- 
low-up of 3.1 years. None required further interventions. In contrast, 14 (82%) of the 17 
group III patients had moderate to severe AR prior to surgery. The regurgitation improved 
in 10, but remained moderate or severe in 4 and worsened further in 3 at a median fol- 
low-up of 4.6 years. The freedom from failure of aortic valvoplasty was (mean±SEM) 
71±11%, 64±12% and 43±19% at 1, 5 and 10 years, respectively. An older age at latest 
follow-up was the only identifiable significantly risk factor (p=0.03). 
Conclusions: Our data do not support the need of aortic valvoplasty for mild to moderate 
aortic cusp prolapse. Close follow-up is warranted in those with moderate to severe cusp 
prolapse despite valvoplasty as there is continued failure on follow-up. Nothing, however, 
is better than early closure of defects before development of aortic valve complications. 
1120- I01 Power M-Mode Tranecranial Doppler Assessment of 
Cerebral Microemboli During Percutsneous Closure of 
Patent Foramen Ovale 
Merdll P. Soencar, Mark Moehring, John White, Craig Heidmiller, William Gray, Mark 
Reisman, John Olsen, Kimberly Krabilt, Spencer Vascular Incorporated, Seattle, 
Washington, Swedish Heart Center, Seattle, Washington. 
Background: Percutaneous closure of patent foramen ovale (PFO) is an increasingly via- 
ble alternative to surgical PFO repair. Air embolism and device maldeployment represent 
the major potential procedural complications. We assessed the diagnostic accuracy of a 
newly developed 33-gate power m-mode transcranial Doppler (pmTCD) versus transe- 
sophageal echocardiography (TEE), and its sensitivity to detect microemboli compared 
to single-gate TCD (sgTCD). 
Methods: Fifteen consecutive patients with a median age of 54 years (range 31-82 years) 
undergoing percutaneous closure of a PFO using a CardioSealR occluder using TEE 
guidance were monitored with bilateral 2 MHz pmTCD. The temporal bone beams inter- 
sected the ipsilateral ICA, MCA, and ACA producing directional color flow representa- 
tions of these arteries, sgTCD spectrograms of the MCAs were simultaneously 
displayed. Embolic signals were represented on power mode as time/depth embolic 
tracks (ET) and on the sgTCD as audible chirps and their counts compared. Following 
device deployment, ET were also counted during contrast injections and compared with 
TEE assessment of closure. 
Results: The occluder was successfully deployed in all patients with no clinical complica- 
tions. ET were detected during venous access with short sheath in 13 of 14 monitored 
patients. ET were detected in all phases of the procedure (mean total 348, range 82- 
865), but most prominently during the deployment of the left atrial umbrella (mean 205, 
range 56-512). Post-deployment agitated contrast in)ection demonstrated complete 
occlusion in 6/15 patients, with some residual shunting in 9 patients, pmTCD concor- 
dance with TEE after deployment was 100%. pmTCD proved 2 times more sensitive for 
microemboli than sgTCD. The following day no ambient microemboli were detected. 
Conclusions: 1. The potential for embolic complication appears to exist throughout all 
phases of this procedure, most prominently during deployment of left atrial umbrella. 2. 
Power m-mode TCD is highly sensitive to emboli regardless of PFO size, is equivalent to 
TEE in assessing adequate closure, and is more sensitive for cerebral microemboli than 
single gate TCD. 
1120-102 Long-Term Results of  Apical  Aort ic  Valved Conduits in 
Children With Complex Left Ventricular Outflow Tract 
Obstruction 
John W. Brown, Mark Ruzmetov, Palaniswamy Vijay, Mark W. Turrentine, Indiana 
University School of Medicine, Indianapolis, Indiana. 
Background: Treatment of congenital left ventdcular outflow tract obstruction (LVOTO) 
with apicoaortic conduit (AAC) show good short and medium term results, although late 
problems are not uncommon. This report summarizes our clinical.expedence with AAC 
conduits in children with emphasis on hemodynamics results, reoperation, and long-term 
follow-up. 
Methods: 30 patients (age range, 2 weeks to 19 years) who underwent insertion of an 
apicoaortic-valved conduit between September 1979 and June t993 are reviewed. All 
patients had complex forms of LVOTO. All were symptomatic, and 22 (73%) had had one 
or two previous aortic valvotomies or LV tract operations, or both. 
Results: There were 4 eady (13.3%) and 5 late (16.7%) deaths and one heart transplan- 
tation. Twenty-six children survived the perioperetive period and improved, and 21 have 
had one or more cardiac catheterization from 3 months to 18 years (mean, 6.2 yr) after 
the initial operation. A demonstrated reduction or resolution of their resting LV-to-aortic 
gradient in early postoperative period from 91+30 to 13+8 mm Hg was demonstrated 
(P<0.001). Four patients who have mechanical valves are taking anticoagulants, and no 
thromboembolic events have occurred. Fourteen survival patients (54%) had undergoing 
subsequent procedures (n=18) from 1.5 months to 11 years postoperatively (mean, 5.5 
yr) with LV-to-aortic gradient 58+28 mm Hg (P<0.002): conduit valve replacement (n=5), 
conduit removal (n=5), resection membrane with myothomy and myectomy (n=3), aor- 
toventriculoplasty (n=2), Ross procedure (n=2), and patch conduit angioplasty (n=t). 
Conclusion: These data demonstrated that the AAC was effective in re,laving complex 
LVOTO and improvement in LV performance with acceptable mid-term results, but with 
frequency late complications. 
